Ardelyx Moves Phase II IBS Drug Forward After Closing $30 Million Financing
This article was originally published in The Pink Sheet Daily
Executive Summary
The funding for the Freemont, Calif., startup includes existing investors New Enterprise Associates, CMEA and new investor Amgen Ventures.